Last reviewed · How we verify

NCT03164226

Prognostic Value of Non-invasive Index of Endothelial Function.

Completed NA Last updated 9 December 2021
What this trial tests

NA trial testing Digital plethysmography in stratifying the cardiovascular risk for patients consulting for chest pain in Chest Pain in 503 participants. Completed in 15 September 2017.

Timeline
15 March 2016
Primary endpoint
15 September 2017
15 September 2017

Quick facts

Lead sponsorUniversity of Monastir
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment503
Start date15 March 2016
Primary completion15 September 2017
Estimated completion15 September 2017
Sites1 location across Tunisia

Drugs / interventions tested

Conditions studied

Sponsor

University of Monastir

Who can join

25 and older, any sex, with Chest Pain or Major Adverse Cardiovascular Events. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to determine the prognostic performance of endothelial function assessment, using endothelial peripheral arterial tonometry (Endo-PAT), associated to TIMI risk score, in patients consulting the emergency department for non-traumatic chest pain. To determine the sensitivity, specificity, negative and positive predictive value of this method that was not previously used for this purpose.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Chest Pain

Currently open trials in the same condition.

Other University of Monastir trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03164226.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing